6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
7m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
12m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
17m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
17m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
17m ago	KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion

About

36.27USD+1.33 +3.81%

Closed • Updated at 13:33 GMT+00:00

Market Cap$3.82B

Volume666.6K

Beta1.00

RSI43.82

Gross Margin70.11%

Health TechnologyPharmaceuticals: Major

Crinetics Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer

Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly

Community Chat

Ask AI